# An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

> **NCT05364086** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Rochester NCORP Research Base** · enrollment: 2100 (estimated)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Electronic Health Record Review
- **OTHER:** Interview
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT05364086
- **Lead sponsor:** University of Rochester NCORP Research Base
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-26
- **Primary completion:** 2026-10-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364086, "An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05364086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*